Search results
Omni Version Test of the Panel of AI Experts on a New Topic: “AI Mentors of New Attorneys” – Part...
JD Supra· 5 days agoRalph Losey’s custom GPT, Panel of AI Experts for Lawyers, was tested again to evaluate its effectiveness on ChatGPT4o Omni. This time an entirely new topic ...
US health experts vote against MDMA as treatment for PTSD | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 3 days agoA panel of US health experts convened by the Food and Drug Administration on Tuesday overwhelmingly...
MDMA Therapy for PTSD? FDA considers first psychedelic drug
KNBN Rapid City· 4 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
FDA sets panel review for IceCure's breast cancer treatment By Investing.com
Investing.com· 3 days agos ProSense® System, a minimally invasive cryoablation technology designed for the treatment of...
Controversy Grows as FDA Panel Prepares to Review MDMA Drug
Medscape· 5 days agoA US Food and Drug Administration (FDA) expert panel will meet Tuesday to consider whether to...
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 8 hours agoIn a briefing document prepared for the advisory committee, the FDA raised questions about a unique...
After ‘sobering’ FDA panel, psychedelics supporters wonder what’s next
BioPharma Dive via Yahoo Finance· 9 hours agoA vote against MDMA-assisted therapy set back a high-profile treatment. Proponents argue the panel...
In review of Lilly Alzheimer’s drug, FDA staff focus on safety, patient selection
BioPharma Dive via Yahoo Finance· 1 day agoThe agency is seeking input from an advisory panel on whether donanemab is effective across...
FDA Panel Rejects Use of MDMA-Assisted Therapy for PTSD
Healthline via AOL· 2 days agoAn expert panel of the Food and Drug Administration reviewed finding from two phase 3 clinical...
An uptick in most significant level of device recalls
Politico· 5 hours agoJUUL GETS ANOTHER SHOT — The FDA said Thursday it is pulling back...denied,” the FDA said. “Rescission of the MDOs returns the applications to pending status, under substantive review ...
